Virginia Regulatory Town Hall
Agency
Department of Medical Assistance Services
 
GDForum ID: 1971
Description of Proposed Guidance Document Changes
The purpose of this memo is to notify Medicaid enrolled pharmacy providers that DMAS fee-for-service (FFS) and the Medicaid Managed Care Organizations will provide up to five professional dispense fees per month (defined as a rolling 30 day period) for buprenorphine-based opioid use disorder (OUD) products, effective December 1, 2022.
 
Guidance Document(s) for this Comment Forum
 
Document ID Document Title Document in Effect Proposed Document
7294 Draft: Increased Reimbursement of Medications for the Treatment of Opioid Use Disorder n/a pdf Proposed Document
 
Contact Information
 
Name:
Meredith Lee
        Title:
Policy, Regulations, and Manuals Supervisor
 
Email:
Meredith.Lee@dmas.virginia.gov
 
Address:
600 E. Broad St., Suite 1300
 
City:
Richmond
State:  
VA
Zip:  
23219
 
Phone:
(804)371-0552
Fax:  
(804)786-1680
TDD: 
(800)343-0634
 
The Virginia Register
 

Publication Date: 11/7/2022    Volume: 39  Issue: 6
The public comment period began upon publication and lasted for 30 days. It ended on 12/7/2022.
There were no comments

Planned Effective Date:  12/8/2022 
X
ID (You can leave this blank if your agency doesn't use custom document IDs)


Title


  (a new row will be created in the table)
X
Key in part of a contact name, email address or street address and select your contact



View Guidance Documents